Xiaoping Zheng

Title: Innovative Contributions of Inventor Xiaoping Zheng

Introduction

Xiaoping Zheng is a prominent inventor based in Shanghai, China, recognized for his significant contributions to the field of pharmaceuticals. With a total of five patents awarded, Zheng has focused on developing novel compounds that play a vital role in medicinal chemistry.

Latest Patents

Xiaoping Zheng's latest innovations include two noteworthy patents. The first patent describes a thieno[2,3-c]pyridazin-4(1H)-one derivative, which acts as an ACC1 or ACC2 inhibitor. This compound, represented by formula (II) or its isomers and pharmaceutically acceptable salts, holds potential for use in drug formulation targeting these specific inhibitors. The second patent introduces a crystal form of the thieno[2,3-c]pyridazine-4(1H)-one compound, detailing its preparation method and application in drug development as inhibitors of ACC1 and ACC2.

Career Highlights

Throughout his career, Xiaoping Zheng has made impactful advancements while working with leading organizations. Notably, he has been associated with Medshine Discovery Inc. and Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd., where he has contributed to innovative research and development in the pharmaceutical domain.

Collaborations

During his career, Zheng has collaborated with notable professionals, including Zhigan Jiang and Haiying He, leveraging diverse expertise to propel his research forward. Their joint efforts have significantly enhanced the innovation landscape within their projects.

Conclusion

Xiaoping Zheng's innovative work, particularly in the development of ACC1 and ACC2 inhibitors, underscores his commitment to improving therapeutic options in medicine. His patents and collaborative efforts reflect a fruitful career that continues to contribute to the field of pharmaceutical sciences. As he advances in his endeavors, the impact of his inventions is expected to resonate within the industry and beyond.